| Similar Articles |
|---|
 |
Popular Mechanics
April 15, 2009
Erin McCarthy |
Is Fringe's Genetic Monster Possible? Unlike the monster on Fringe, altered animals typically have only a single gene difference from non-altered animals -- but they can look different.   |
BusinessWeek
April 12, 2004
John Carey |
Gene-Based Therapy: Back To The Couch Recent setbacks show (again) that biotech needs more patience and less ballyhoo |
BusinessWeek
June 13, 2005
Catherine Arnst |
Biotech, Finally The past 30 years of biological discoveries, insights into the human genome, and exotic chemical manipulation have unleashed a wave of biological drugs, many of them reengineered human proteins. |
Fast Company
November 2009
David H. Freedman |
The Gene Bubble: Why We Still Aren't Disease-Free When the human genome was first sequenced nearly a decade ago, the world lit up with talk about how new gene-specific drugs would help us cheat death. Well, the verdict is in: Keep eating those greens. |
The Motley Fool
June 21, 2010
Erin Kutz |
Curis Misses Mark in Drug Trial; Genzyme Elects Board; GTC Cuts Jobs; and More Boston-Area Life Sciences News These drug and biomedical companies made news last week. |
Popular Mechanics
September 25, 2009
Erin McCarthy |
Fringe's Human Mutant Not Possible, Says Expert We won't ever have to worry about Fringe's part-mole-rat, part-scorpion, part-human mutant in real life because it's not within the realm of possibility. |
BusinessWeek
January 16, 2006
Arlene Weintraub |
What's Ethical And What Isn't? The debate over using human cells in animals for medical research. |
BusinessWeek
October 18, 2004
Catherine Arnst |
The Waning of the Blockbuster Drug What's promising now are drugs that target niche diseases. That means painful restructuring ahead for Big Pharma |
BusinessWeek
January 29, 2007
Arlene Weintraub |
More Merger Mania Ahead For Pharma The scramble for new drugs is keeping companies on the prowl. |
The Motley Fool
November 8, 2004
Charly Travers |
A Fantastic Cancer-Drug Deal Has Medarex hit the jackpot with MDX-010? Aside from the great financial terms, this deal is an important step in Medarex's transition from a research company to a company with commercial operations. |
Managed Care
November 2006
Thomas Morrow |
Transgenic Drug Production Heads Back to the Farm The use of transgenic goats to produce a recombinant form of human antithrombin is much more efficient than using mammalian cell cultures. |
Chemistry World
October 31, 2007
John Bonner |
Brain's Wiring Seen in Technicolor Researchers in the US have developed a technique that could allow neurologists to draw a detailed wiring plan of the mammalian brain by inserting genes coding for fluorescent proteins into transgenic mice. |
Pharmaceutical Executive
August 1, 2008
Patrick Clinton |
Salute to the Murines What can we say about modern medicine? The answer, of course, is that it's brilliant at curing the ailments of mice. |
The Motley Fool
December 17, 2007
Jack Uldrich |
Innovations and Opportunities The latest scientific news is about fighting aging, heart disease, and cancer. |
BusinessWeek
June 13, 2005
Arlene Weintraub |
Why Biotech Stocks Are Sedated Biotech might seem like a can't-miss investing opportunity but many investors are taking a pass on biotech, even amid bona fide scientific advances. |
The Motley Fool
November 30, 2004
Charly Travers |
Picking Biotech's Winners Doing well as a biotech investor comes as much from avoiding the losers as picking the winners. A quick screen for making winning investment picks. |
The Motley Fool
November 18, 2004
Charly Travers |
A Glimpse of Bristol-Myers' Portfolio Late-stage drugs are crucial for a company beset with patent losses. |
The Motley Fool
August 28, 2006
Brian Lawler |
The Commandments of Biotech Investing Since long-term successful biotech investing requires accurate risk assessment, you must be aware of the risk you're taking on. Just as with any prospective investment, if you diversify your biotech holdings, you can somewhat mitigate these various risks. |
Bio-IT World
January 21, 2005
Mark D. Uehling |
Breeding Mice That Roar Taconic Farms, a leading purveyor of laboratory animals, has built a $10-million facility in Cambridge City, Ind. which will allow express shipping of rats and mice to Midwestern science hubs. |
Scientific American
March 2009
Philip Yam |
Updates: Whatever Happened to Drugs from Goats? Also: updates on nanotech medicine, space shuttle Columbia's last moments, and the five aspects of taste |
HHMI Bulletin
Nov 2010
Sarah C.P. Williams |
Maternal and Paternal Genes Don't Always Have The Same Effect On Offspring The genes you inherited from your mom and those passed along from your dad don't have equal footing when it comes to how they influence your biology. |
